PURPOSE: There is little to guide clinicians in terms of evidence-based interventions for children with cochlear implants who demonstrate morpheme errors. This feasibility study tested the utility of a treatment targeting grammatical morpheme errors. METHOD: Three children (ages 4-5 years) received Enhanced Conversational Recast treatment, a version of conversational recast treatment that focuses on a single morpheme error at a time, emphasizes attention to clinician input, and uses high linguistic variability with clinician input. A period of recasting was followed by 24 auditory presentations of the target morpheme in short sentences. After an initial baseline period, children were treated in individual sessions over 21-26 days. RESULTS: All children showed improved use of targeted grammatical morpheme use, both in elicited contexts and in terms of spontaneous use. Spontaneous use was best for the 2 children who were implanted earliest and whose audiograms showed the best hearing postimplant. Performance by a 3rd child diagnosed with auditory neuropathy spectrum disorder was more variable but still showed positive change. CONCLUSIONS: The results indicate that the treatment can be effective for children with cochlear implants. The pattern of results across children also suggests potential variables that may moderate treatment effects.
PURPOSE: There is little to guide clinicians in terms of evidence-based interventions for children with cochlear implants who demonstrate morpheme errors. This feasibility study tested the utility of a treatment targeting grammatical morpheme errors. METHOD: Three children (ages 4-5 years) received Enhanced Conversational Recast treatment, a version of conversational recast treatment that focuses on a single morpheme error at a time, emphasizes attention to clinician input, and uses high linguistic variability with clinician input. A period of recasting was followed by 24 auditory presentations of the target morpheme in short sentences. After an initial baseline period, children were treated in individual sessions over 21-26 days. RESULTS: All children showed improved use of targeted grammatical morpheme use, both in elicited contexts and in terms of spontaneous use. Spontaneous use was best for the 2 children who were implanted earliest and whose audiograms showed the best hearing postimplant. Performance by a 3rd child diagnosed with auditory neuropathy spectrum disorder was more variable but still showed positive change. CONCLUSIONS: The results indicate that the treatment can be effective for children with cochlear implants. The pattern of results across children also suggests potential variables that may moderate treatment effects.
Authors: P J Blamey; J Z Sarant; L E Paatsch; J G Barry; C P Bow; R J Wales; M Wright; C Psarros; K Rattigan; R Tooher Journal: J Speech Lang Hear Res Date: 2001-04 Impact factor: 2.297
Authors: Emily A Tobey; Donna Thal; John K Niparko; Laurie S Eisenberg; Alexandra L Quittner; Nae-Yuh Wang Journal: Int J Audiol Date: 2013-02-28 Impact factor: 2.117
Authors: Elena Plante; Trianna Ogilvie; Rebecca Vance; Jessica M Aguilar; Natalie S Dailey; Christina Meyers; Anne Marie Lieser; Rebecca Burton Journal: Am J Speech Lang Pathol Date: 2014-11 Impact factor: 2.408